Login

Interim Condensed Consolidated Balance Sheets

In millions of CAD, except per-share amounts
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Mar 31, 2018
Cash and cash equivalents
Restricted cash
Trade and other receivables, net
Unbilled revenues
Gas in storage
Fair value of derivative financial assets
Income taxes recoverable
Other current assets
Total current assets excluding assets classified as held for sale
Assets classified as held for sale
Total current assets
Investments
Property and equipment, net
Intangible assets, net
Goodwill
Deferred income tax assets
Other non-current assets
Noncurrent assets, excluding assets held for sale
Total non-current assets
TOTAL ASSETS
Trade and other payables
Deferred revenue
Income taxes payable
Fair value of derivative financial liabilities
Provisions
Current portion of long-term debt
Total current liabilities excluding liabilities associated with assets classified as held for sale
Liabilities relating to assets classified as held for sale
Total current liabilities
Long-term debt
Deferred income tax liabilities
Other non-current liabilities
Non-current liabilities other than liabilities included in disposal groups classified as held for sale
Total non-current liabilities
TOTAL LIABILITIES
Shareholders' capital
Equity component of convertible debentures
ASSETS
Current assets
Cash and cash equivalents
Restricted cash
Trade and other receivables, net
Securitization proceeds receivable from ERCOT
Gas in storage
Derivative instruments
Income taxes recoverable
Other current assets
Total current assets
Non-current assets
Investments
Property and equipment, net
Intangible assets, net
Goodwill
Derivative instruments
Deferred income taxes
Other non-current assets
Total non-current assets
TOTAL ASSETS
Liabilities
LIABILITIES
Current liabilities
Trade and other payables
Deferred revenue
Income taxes payable
Derivative instruments
Provisions
Current portion of long-term debt
Total current liabilities
Liabilities subject to compromise
Non-current liabilities
Long-term debt
Derivative instruments
Deferred income taxes
Other non-current liabilities
Total non-current liabilities
TOTAL LIABILITIES
SHAREHOLDERS' EQUITY
Common shares, no par value; unlimited shares authorized at September 30, 2022 and March 31, 2022; 48,078,637 shares issued and outstanding at September 30, 2022; 48,078,637 shares issued and outstanding at March 31, 2022
Contributed deficit
TOTAL SHAREHOLDERS' DEFICIT
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT
Accumulated deficit
Accumulated other comprehensive income
Non-controlling interest
TOTAL SHAREHOLDERS' EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support